Weight Loss Drug Safety Questioned by FDA
FDA and Industry Officials Disagree Over Ephedra
Questions are being raised as to whether the dietary supplement ephedra is safe and effective or potentially dangerous. The Food & Drug Administration (FDA) recently outlined 100 reports of serious health problems they link to products containing the supplement. The reports, collected for almost two years, include 46 cases of cardiovascular problems-including seven deaths by cardiac arrest-and 41 cases of central-nervous-system problems such as stimulant effects and seizures.
Industry representatives criticized the FDA's data and attribute the reported health problems to underlying conditions, use of multiple products, and excessive fasting and exercise. A medical examiner that reviewed 22 deaths possibly linked to ephedra products said that all but two cases were likely caused by other medical problems.
Because ephedra is a dietary supplement, the FDA must treat it as a food supplement and not as a drug. For more information visit the Food & Drug Administration website at www.fda.gov.
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
